Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses

[1]  Justine C. Williams,et al.  A long interval between priming and boosting SARS-CoV-2 mRNA vaccine doses enhances B cell responses with limited impact on T cell immunity , 2022, bioRxiv.

[2]  Justin M. Richner,et al.  Pre-existing immunity modulates responses to mRNA boosters , 2022, bioRxiv.

[3]  W. Lau,et al.  Early human B cell signatures of the primary antibody response to mRNA vaccination , 2022, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Gheyath K Nasrallah,et al.  Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections , 2022, The New England journal of medicine.

[5]  Lauren M. Hickling,et al.  Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure , 2022, Science.

[6]  D. Bhattacharya,et al.  Instructing durable humoral immunity for COVID-19 and other vaccinable diseases , 2022, Immunity.

[7]  M. Nussenzweig,et al.  Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost , 2022, Nature.

[8]  B. Palmer,et al.  SARS-CoV-2 infection relaxes peripheral B cell tolerance , 2022, The Journal of experimental medicine.

[9]  Justine C. Williams,et al.  Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine , 2022, Cell.

[10]  J. Mascola,et al.  mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron , 2022, Cell.

[11]  S. Fukushi,et al.  SARS-CoV-2 Omicron-neutralizing memory B-cells are elicited by two doses of BNT162b2 mRNA vaccine , 2022, Science Immunology.

[12]  A. Sigal.  Milder disease with Omicron: is it the virus or the pre-existing immunity? , 2022, Nature Reviews Immunology.

[13]  M. Gale,et al.  Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity , 2022, Cell.

[14]  J. Mascola,et al.  Molecular probes of spike ectodomain and its subdomains for SARS-CoV-2 variants, Alpha through Omicron , 2021, bioRxiv.

[15]  A. Ellebedy,et al.  The germinal centre B cell response to SARS-CoV-2 , 2021, Nature reviews. Immunology.

[16]  Chaim A. Schramm,et al.  Protection against SARS-CoV-2 Beta variant in mRNA-1273 vaccine–boosted nonhuman primates , 2021, Science.

[17]  R. Rappuoli,et al.  Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants , 2021, Nature.

[18]  Aaron M. Rosenfeld,et al.  mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern , 2021, Science.

[19]  Rosalind J Wright,et al.  Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine , 2021, Cell.

[20]  J. Mascola,et al.  COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge , 2021, Immunity.

[21]  S. Reis,et al.  Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States , 2021, Science Translational Medicine.

[22]  N. Baumgarth.  The Shaping of a B Cell Pool Maximally Responsive to Infections. , 2021, Annual review of immunology.

[23]  A. Sette,et al.  Adaptive immunity to SARS-CoV-2 and COVID-19 , 2021, Cell.

[24]  J. Mascola,et al.  Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine , 2020, The New England journal of medicine.

[25]  P. Dormitzer,et al.  Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine , 2020, The New England journal of medicine.

[26]  D. Esposito,et al.  Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays , 2020, Protein Expression and Purification.

[27]  William T. Hu,et al.  Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19 , 2020, Nature Immunology.

[28]  Lisa E. Wagar,et al.  An Integrated Multi-omic Single-Cell Atlas of Human B Cell Identity , 2020, Immunity.

[29]  D. Esposito,et al.  Optimizing high-yield production of SARS-CoV-2 soluble spike trimers for serology assays , 2020, bioRxiv.

[30]  T. Kurosaki,et al.  Restricted Clonality and Limited Germinal Center Reentry Characterize Memory B Cell Reactivation by Boosting , 2019, Cell.

[31]  Chaim A. Schramm,et al.  Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B cell Responses to Influenza Hemagglutinin. , 2019, Immunity.

[32]  T. Dörner,et al.  Postactivated B cells in systemic lupus erythematosus: update on translational aspects and therapeutic considerations , 2019, Current opinion in rheumatology.

[33]  G. Gibson,et al.  Distinct Effector B Cells Induced by Unregulated Toll‐like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus , 2018, Immunity.

[34]  T. Chun,et al.  IgG3 regulates tissue-like memory B cells in HIV-infected individuals , 2018, Nature Immunology.

[35]  J. Cambier,et al.  B lymphocyte antigen receptor signaling: initiation, amplification, and regulation , 2013, F1000prime reports.

[36]  Michael Meyer-Hermann,et al.  Germinal center B cells govern their own fate via antibody feedback , 2013, The Journal of experimental medicine.

[37]  M. Clark,et al.  Germinal Center B-cells , 2012, Autoimmunity.

[38]  M. Diamond,et al.  Memory B cells, but not long-lived plasma cells, possess antigen specificities for viral escape mutants , 2011, The Journal of experimental medicine.

[39]  F. Gage,et al.  Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. , 1996, Proceedings of the National Academy of Sciences of the United States of America.